Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry

[1]  M. Jaguszewski,et al.  Pharmacotherapy of atrial fibrillation in COVID-19 patients , 2021, Cardiology journal.

[2]  C. Macaya,et al.  [Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry]. , 2021, Revista espanola de cardiologia.

[3]  Alfarooq M. Alshaikhli,et al.  New-Onset Atrial Fibrillation and Multiple Systemic Emboli in a COVID-19 Patient , 2021, Cureus.

[4]  G. Lip,et al.  Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19 , 2020, Journal of arrhythmia.

[5]  J. Z. Zamorano Gómez,et al.  New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. , 2020, Cardiology journal.

[6]  M. Méndez-Bailon,et al.  Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  Utkarsh Kohli,et al.  Fulminant myocarditis and atrial fibrillation in child with acute COVID-19 , 2020, Journal of Electrocardiology.

[8]  S. Yusuf,et al.  Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation , 2020, European heart journal.

[9]  D. Dobrev,et al.  COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications , 2020, IJC Heart & Vasculature.

[10]  Benjamin S. Glicksberg,et al.  Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 , 2020, Journal of the American College of Cardiology.

[11]  J. Ramos-Rincón,et al.  Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry☆ , 2020, Revista Clínica Española (English Edition).

[12]  J. Ramos-Rincón,et al.  Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry , 2020, Revista Clínica Española (English Edition).

[13]  W. Ullah,et al.  COVID-19 Presenting as Takotsubo Cardiomyopathy Complicated with Atrial Fibrillation , 2020, IJC Heart & Vasculature.

[14]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[15]  F. Chorro,et al.  Prevalence of atrial fibrillation in Spain. OFRECE study results. , 2014, Revista espanola de cardiologia.

[16]  J. Pérez-Villacastín,et al.  Epidemiology of atrial fibrillation in Spain in the past 20 years. , 2013, Revista espanola de cardiologia.

[17]  R. Franken,et al.  Atrial fibrillation in the elderly , 2012, Journal of geriatric cardiology : JGC.

[18]  A. Feinstein,et al.  A new clinical index of growth rate in the staging of breast cancer. , 1980, The American journal of medicine.

[19]  F. Félix-Redondo,et al.  Prevalence of atrial fibrillation and its associated factors in Spain: An analysis of 6 population-based studies. DARIOS Study. , 2014, Revista clinica espanola.